Abbonarsi

Improved adherence to Swedish national guidelines for acute myocardial infarction: The Quality Improvement in Coronary Care (QUICC) study - 18/08/11

Doi : 10.1016/j.ahj.2006.07.028 
Rickard Carlhed, MD, MSc a, , Mats Bojestig, MD, PhD b, Lars Wallentin, MD, PhD a, Gunilla Lindström, RN a, Anette Peterson, RN b, Christina Åberg, RN a, Bertil Lindahl, MD, PhD a

for the QUICC study group

a Uppsala Clinical Research Center, University Hospital, Uppsala, Sweden 
b Department of Internal Medicine, Eksjö, Sweden 

Reprint requests: Rickard Carlhed, MD, MSc, Clinical Chemistry, Central Hospital, S-651 85 Karlstad, Sweden.

Riassunto

Background

The adherence to evidence-based treatment guidelines for acute myocardial infarction (AMI) is still suboptimal. Therefore, we designed a study to evaluate the effects of a collaborative quality improvement (QI) intervention on the adherence to AMI guidelines. The intervention used a national web-based quality registry to generate local and regular real-time performance feedback.

Methods

A 12-month baseline measurement of the adherence rates was retrospectively collected, comprising the period July 1, 2001, through June 30, 2002. During the intervention period of November 1, 2002, through April 30, 2003, multidisciplinary teams from 19 nonrandomized intervention hospitals were subjected to a multifaceted QI-oriented intervention. Another 19 hospitals, unaware of their status as controls, were matched to the intervention hospitals. During the postintervention measurement period of May 1, 2003, through April 30, 2004, a total of 6726 consecutive patients were included at the intervention (n = 3786) and control (n = 2940) hospitals. The outcome measures comprised 5 Swedish national guideline-derived quality indicators, compared between baseline and postintervention levels in the control and QUICC intervention hospitals.

Results

In the control and QI intervention hospitals, the mean absolute increase of patients receiving angiotensin-converting enzyme inhibitors was 1.4% vs 12.6% (P = .002), lipid-lowering therapy 2.3% vs 7.2% (P = .065), clopidogrel 26.3% vs 41.2% (P = .010), heparin/low–molecular weight heparin 5.3% vs 16.3% (P = .010), and coronary angiography 6.2% vs 16.8% (P = .027), respectively. The number of QI intervention hospitals reaching a treatment level of at least 70% in 4 or 5 of the 5 indicators was 15 and 5, respectively. In the control group, no hospital reached 70% or more in just 4 of the 5 indicators.

Conclusions

By combining a systematic and multidisciplinary QI collaborative with a web-based national quality registry with functionality allowing real-time performance feedback, major improvements in the adherence to national AMI guidelines can be achieved.

Il testo completo di questo articolo è disponibile in PDF.

Mappa


 This study was supported by the Federation of Swedish County Councils, Stockholm, Sweden.
 The funding agency had no direct role in the conduct of the study, the collection, management, statistical analyses, and interpretation of the data, preparation, or approval of the manuscript.
 Bertil Lindahl has received fees for speaking on satellite symposia and other educational meetings from Roche Diagnostica, Dade-Behring, Beckman-Coulter and Merck Sharp and Dohme.
 Proressor Lars Wallentin has been involved in clinical trials and received research grants from pharmaceutical companies, that is, Sanofi-Aventis, Astra-Zeneca, Boehringer-Ingelheim, Lilly, GSK, and Pfizer.
 Rickard Carlhed, Mats Bojestig, Christina Åberg, Gunilla Lindström, and Anette Peterson declare that no competing interests exist.


© 2006  Mosby, Inc. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 152 - N° 6

P. 1175-1181 - Dicembre 2006 Ritorno al numero
Articolo precedente Articolo precedente
  • Angioscopic evaluation of neointima coverage: Sirolimus drug-eluting stent versus bare metal stent
  • Jota Oyabu, Yasunori Ueda, Nobuyuki Ogasawara, Katsuki Okada, Atsushi Hirayama, Kazuhisa Kodama
| Articolo seguente Articolo seguente
  • Evaluation of dyslipidemia in the emergency department: Impact of cholesterol testing on subsequent therapy
  • Andra L. Blomkalns, Elise M. O'Connell, Caroline E. Eady, Christopher J. Lindsell, W. Brian Gibler

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2025 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.